Antagonists of the human A2A receptor. Part 5: Highly bio-available pyrimidine-4-carboxamides

A novel series of antagonists of the human A2A receptor have been identified and have been shown to display good potency and high degrees of selectivity over other receptor sub-types. Displaying in vivo potency in commonly used disease models and high oral bio-availability, this class of compounds may serve as clinically useful treatments for the relief of the symptoms associated with Parkinson’s disease.

A novel series of antagonists of the human A2A receptor demonstrate potency and selectivity over other receptor sub-types. Displaying in vivo potency in commonly used disease models and high oral bio-availability, this class of compounds may serve as clinically useful treatments for the relief of the symptoms associated with Parkinson’s disease.Figure optionsDownload as PowerPoint slide